AgelessRx offers an online NAD+ injection program and a wider catalog of NAD-related products. Its current injection page describes clinician assessment, compounded medication, ongoing support, and several payment-plan details that deserve more attention than the opening price alone.
This is public-page research checked September 23, 2026. We have not enrolled as a patient or independently tested the prescription, clinical service, customer survey, or pharmacy process. The distinction matters when a page places strong benefit claims next to a purchase button.
THE USEFUL DISTINCTION
The advertised $79 first month has a three-month-plan condition; it is not the stated ongoing monthly price.
Identify which product you are reviewing
The company’s catalog includes several routes, such as injections and nasal products. This review concerns the NAD+ injection page. A catalog-wide claim or experience reported for one route should not be treated as evidence for every other route the company sells.
The page describes a compounded prescription service subject to clinician assessment. Ask what formulation would actually be prescribed and how it would be supplied. Our molecule comparison explains another source of confusion: studies involving NR or NMN cannot simply be relabeled as trials of the offered NAD+ injection.
Evidence: AgelessRx: NAD+ injections / AgelessRx: NAD support catalog / Martens et al.: 2018 oral NR crossover trial
Unpack the initial payment
The public page advertises $79 for the first month on a three-month plan billed in full, with $149 per month afterward. This is materially different from an unrestricted $79 month-to-month offer. The total initial invoice and renewal amount should be confirmed before making a payment decision.
Ask how the advertised cancellation or pause option interacts with a prepaid term, shipments already sent, and clinical access. Our cost explanation encourages comparison of the actual commitment rather than one introductory number. This review records the published terms, not a checkout-tested quote for a particular reader.
Evidence: AgelessRx: NAD+ injections
Survey percentages are a different kind of evidence
AgelessRx uses customer-reported experience in its marketing. A survey of people receiving a service can describe respondents’ reports, but it lacks the same protections against bias as a randomized, blinded trial with an appropriate control. Who responds, expectations, and other changes in care can affect the findings.
We therefore do not convert the company’s percentages into a predicted probability of benefit. The evidence explorer gives examples of how to inspect a study’s actual design. A provider survey, an oral precursor trial, and a small IV pilot should retain their separate identities.
Evidence: AgelessRx: NAD support catalog / Martens et al.: 2018 oral NR crossover trial / Grant et al.: 2019 IV NAD+ metabolome pilot
Ask about the finished medication
The injection page describes dispensing through a licensed compounding pharmacy. Confirm the pharmacy that would fill your prescription, the label and storage instructions, the beyond-use information, and the process for a shipment concern. A general quality statement is not the same as inspecting your actual preparation.
FDA’s NAD-related sterile-compounding alert belongs in this discussion. Read the safety guide for the warning about unsuitable food-grade ingredients and reported reactions. We did not identify a product-specific contamination finding for this review; we also did not perform a sterile-compounding audit that could independently rule out quality problems.
Evidence: AgelessRx: NAD+ injections / FDA: suitable ingredients for sterile compounding / FDA: compounding and approval
Understand what ongoing support means
The public offer describes messaging, check-ins, and clinician-guided adjustments. Before enrollment, ask who reviews those messages, when a medical issue needs a separate visit, and how urgent symptoms should be handled. Routine online support should not be assumed to function as emergency care.
Confirm availability for your physical location and how the service coordinates with your existing clinician. Avoid taking an advertised dosing example as a personal instruction. The injection and infusion comparison focuses on care responsibilities because the route and the support arrangement both affect what you need to understand.
Evidence: AgelessRx: NAD+ injections / HHS: telehealth licensing / FDA: BeSafeRx
Compare without awarding an invented score
The CoreAge review provides another public injection offer with a different advertised starting price. The Elysium review concerns an oral supplement and should not be treated as an interchangeable prescription provider. Evidence, product category, and billing terms all need their own comparison.
Our featured shortlist places CoreAge first under a paid arrangement. We have not measured which service delivers better clinical outcomes, faster clinician responses, or more reliable pharmacy production. Public marketing is useful research material, but it cannot supply those independent conclusions on its own.
Evidence: CoreAge Rx: NAD+ injectable product page / Elysium: Basis product and subscription terms / AgelessRx: NAD+ injections
Open the source material
- AgelessRx: NAD+ injections
Advertised $79 first month on a three-month plan billed in full, then $149 per month. Confirm final terms; surveys are not controlled trials.
- AgelessRx: NAD support catalog
Different routes are distinct products. Catalog claims do not establish equivalent clinical outcomes.
- Martens et al.: 2018 oral NR crossover trial
Small, short-duration human study of oral NR; cannot establish effectiveness of injectable NAD+.
- Grant et al.: 2019 IV NAD+ metabolome pilot
Eight NAD+ recipients and three saline controls; short-term metabolite measurements, not a longevity or clinical efficacy trial.
- FDA: suitable ingredients for sterile compounding
Specific NAD+ safety communication: food-grade material, contamination risk and reported adverse events.
- FDA: compounding and approval
Compounded drugs are not FDA-approved; ingredient evidence does not certify the finished preparation.
- HHS: telehealth licensing
General licensure guidance. Individual state availability must be checked directly.
- FDA: BeSafeRx
Online pharmacy checks, not certification of a particular brand.
- CoreAge Rx: NAD+ injectable product page
Commercial description and starting price checked September 23, 2026. Benefit claims are not independent efficacy evidence.
- Elysium: Basis product and subscription terms
Oral NR plus pterostilbene supplement, not injectable NAD+. Marketing and purchase terms are separate from clinical trial results.
